258 related articles for article (PubMed ID: 23445199)
41. Focal segmental glomerulosclerosis, crescent, and rapidly progressive renal failure.
Ramirez F; Travis LB; Cunningham RJ; Cavallo T; Rajarman S; Brouhard BH; Ellis EN
Int J Pediatr Nephrol; 1982 Sep; 3(3):175-8. PubMed ID: 7141789
[TBL] [Abstract][Full Text] [Related]
42. Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?
Soliman NA; Francis M; Heeringa SF; Chernin G
Pediatr Nephrol; 2009 May; 24(5):1065-70. PubMed ID: 18853198
[TBL] [Abstract][Full Text] [Related]
43. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
Hyla-Klekot L; Grenda R; Pulcer B
Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
[TBL] [Abstract][Full Text] [Related]
44. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
45. Treatment of focal segmental glomerulosclerosis.
Meyrier A
Expert Opin Pharmacother; 2005 Aug; 6(9):1539-49. PubMed ID: 16086641
[TBL] [Abstract][Full Text] [Related]
46. Differential risk of remission and ESRD in childhood FSGS.
Gipson DS; Chin H; Presler TP; Jennette C; Ferris ME; Massengill S; Gibson K; Thomas DB
Pediatr Nephrol; 2006 Mar; 21(3):344-9. PubMed ID: 16395603
[TBL] [Abstract][Full Text] [Related]
47. Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades.
Beer A; Mayer G; Kronbichler A
Biomed Res Int; 2016; 2016():4192578. PubMed ID: 27144166
[TBL] [Abstract][Full Text] [Related]
48. [Membranous nephropathy].
Yokoyama H; Yoshimoto K; Wada T
Nihon Rinsho; 2004 Oct; 62(10):1856-60. PubMed ID: 15500130
[TBL] [Abstract][Full Text] [Related]
49. Steroid-responsive focal segmental glomerulosclerosis in primary antiphospholipid syndrome with successful pregnancy outcome.
Bhowmik D; Dadhwal V; Dinda AK; Handa R; Dash SC
Nephrol Dial Transplant; 2005 Aug; 20(8):1726-8. PubMed ID: 15919690
[No Abstract] [Full Text] [Related]
50. Progression of orthostatic proteinuria to focal and segmental glomerulosclerosis.
Berns JS; McDonald B; Gaudio KM; Siegel NJ
Clin Pediatr (Phila); 1986 Mar; 25(3):165-6. PubMed ID: 3948459
[TBL] [Abstract][Full Text] [Related]
51. Acute kidney injury in primary nephrotic syndrome: report of nine cases in Siriraj Hospital.
Larpparisuth N; Chanchairujira T; Chawanasuntorapoj R; Choensuchon B; Vareesangthip K; Vasuvattakul S; Teerapornlertratt T
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S125-33. PubMed ID: 21721438
[TBL] [Abstract][Full Text] [Related]
52. Evaluation and management of steroid-sensitive nephrotic syndrome.
Hodson EM; Alexander SI
Curr Opin Pediatr; 2008 Apr; 20(2):145-50. PubMed ID: 18332709
[TBL] [Abstract][Full Text] [Related]
53. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
[TBL] [Abstract][Full Text] [Related]
54. Partial remission of resistant nephrotic syndrome after oral galactose therapy.
Kopač M; Meglič A; Rus RR
Ther Apher Dial; 2011 Jun; 15(3):269-72. PubMed ID: 21624074
[TBL] [Abstract][Full Text] [Related]
55. Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology.
Dogra S; Kaskel F
Pediatr Nephrol; 2017 Jun; 32(6):965-974. PubMed ID: 27783158
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of nephrotic syndrome in the adult].
Gero L
Orv Hetil; 2006 Dec; 147(48):2313-8. PubMed ID: 17256632
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
Segarra Medrano A; Vila Presas J; Pou Clavé L; Majó Masferrer J; Camps Doménech J
Nefrologia; 2011; 31(3):286-91. PubMed ID: 21468162
[TBL] [Abstract][Full Text] [Related]
58. Update in pathophysiology and histopathology of focal segmental glomerulosclerosis.
Kanjanabuch T; Lewsuwan S; Kitiyakara C; Cheunsuchon B; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S262-79. PubMed ID: 17044482
[TBL] [Abstract][Full Text] [Related]
59. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
Kumar J; Shatat IF; Skversky AL; Woroniecki RP; Del Rio M; Perelstein EM; Johnson VL; Mahesh S
Pediatr Nephrol; 2013 Feb; 28(2):333-8. PubMed ID: 23052653
[TBL] [Abstract][Full Text] [Related]
60. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
Jayaraman VK; Thomas M
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26887886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
